Skip to main content

Table 4 Association of HLA-DRB1 alleles with the SE, HLA-DR3, and DERAA motif with ACPA+ or ACPA- rheumatoid arthritis

From: Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor

  

Controls

(n = 269)

Rheumatoid arthritis patients

(n = 231)

   

ACPA+(n = 143)

ACPA-(n = 88)

    

P value

OR, 95% CI

 

P value

OR, 95% CI

SE

Absence, n (%)

157 (58.4)

46 (32.2)

0.0001

2.95, 1.93-4.53

57 (64.8)

0.31

0.76, 0.46-1.27

 

Presence, n (%)

112 (41.6)

97 (67.8)

  

31 (35.2)

  

DR3

Absence, n (%)

216 (80.3)

125 (87.4)

0.07

0.58, 0.32-1.04

63 (71.6)

0.10

1.61, 0.93-2.80

 

Presence, n (%)

53 (19.7)

18 (12.6)

  

25 (28.4)

  

DERAA

Absence, n (%)

197 (73.2)

118 (82.5)

0.03

0.58, 0.34-0.64

58 (65.9)

0.22

1.41, 0.84-2.37

 

Presence, n (%)

72 (26.8)

25 (17.5)

  

30 (34.1)

  
  1. ACPA, anti-citrullinated protein antibody; CI, confidence interval; DERAA, DERAA-encoding allele; DR3, HLA-DR3; OR, odds ratio; SE, shared epitope allele.